Testimonies, • 08/09/2022 Dave Pounds - MDMA for Alcohol Use Disorder Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder Previous Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression You Might Also Like Ongoing trials investigating psychedelic-assisted therapies Presentation of the results of ketamine-assisted therapy program for treatment resistant depression Tadeusz Hawrot PAREA: "Specificità e sinergie della ricerca terapeutica con psichedelici in Europa" Launch of the Psychedelic Access and Research European Alliance DAVOS: Brain Capital, Psychedelics & Human Flourishing
Testimonies, • 08/09/2022 Dave Pounds - MDMA for Alcohol Use Disorder Dave Pounds was a participant in AWAKN Life Science's Clinical Trial - MDMA for Alcohol Use Disorder Previous Maryam Jabir - challenging, unresolved psychedelic experience: psilocybin therapy for treatment resistant depression You Might Also Like Ongoing trials investigating psychedelic-assisted therapies Presentation of the results of ketamine-assisted therapy program for treatment resistant depression Tadeusz Hawrot PAREA: "Specificità e sinergie della ricerca terapeutica con psichedelici in Europa" Launch of the Psychedelic Access and Research European Alliance DAVOS: Brain Capital, Psychedelics & Human Flourishing
